Chimerix Inc (CMRX)
0.9993
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
0.9983
0.00 (0.00%)
After-Hours: 20:00
Chimerix Accounts Payable (Quarterly): 3.823M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.823M |
December 31, 2023 | 2.851M |
September 30, 2023 | 2.502M |
June 30, 2023 | 1.823M |
March 31, 2023 | 2.847M |
December 31, 2022 | 3.034M |
September 30, 2022 | 3.282M |
June 30, 2022 | 1.743M |
March 31, 2022 | 3.494M |
December 31, 2021 | 2.788M |
September 30, 2021 | 1.792M |
June 30, 2021 | 1.457M |
March 31, 2021 | 2.181M |
December 31, 2020 | 1.283M |
September 30, 2020 | 0.88M |
June 30, 2020 | 1.425M |
March 31, 2020 | 1.124M |
December 31, 2019 | 2.398M |
September 30, 2019 | 3.477M |
June 30, 2019 | 1.832M |
March 31, 2019 | 2.492M |
December 31, 2018 | 4.691M |
September 30, 2018 | 1.609M |
Date | Value |
---|---|
June 30, 2018 | 1.426M |
March 31, 2018 | 1.892M |
December 31, 2017 | 3.812M |
September 30, 2017 | 1.571M |
June 30, 2017 | 1.609M |
March 31, 2017 | 2.813M |
December 31, 2016 | 3.89M |
September 30, 2016 | 3.28M |
June 30, 2016 | 4.217M |
March 31, 2016 | 3.568M |
December 31, 2015 | 10.46M |
September 30, 2015 | 12.92M |
June 30, 2015 | 9.819M |
March 31, 2015 | 6.92M |
December 31, 2014 | 5.938M |
September 30, 2014 | 5.846M |
June 30, 2014 | 3.055M |
March 31, 2014 | 1.806M |
December 31, 2013 | 2.214M |
September 30, 2013 | 1.77M |
June 30, 2013 | 0.995M |
March 31, 2013 | 2.711M |
December 31, 2012 | 1.964M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.88M
Minimum
Sep 2020
3.823M
Maximum
Mar 2024
2.302M
Average
2.290M
Median
Accounts Payable (Quarterly) Benchmarks
UFP Technologies Inc | 23.65M |
Dentsply Sirona Inc | 279.00M |
Arbutus Biopharma Corp | 3.743M |
Pacira BioSciences Inc | 15.70M |
Karyopharm Therapeutics Inc | 3.123M |